New Delhi, Oct. 30 -- Cipla Ltd has named chief operating officer Achin Gupta its next chief executive officer and managing director, succeeding Umang Vohra, who is exiting the pharma giant after a de... Read More
New Delhi, Oct. 27 -- Indian hospital chains are expected to post steady growth in the second quarter ended September 30, a weak period compared to previous years on account of lower infection rates, ... Read More
New Delhi, Oct. 24 -- Dr Reddy's Laboratories beat street estimates in the September quarter, with a revenue of Rs.8,805 crore and profit after tax of Rs.1,437 crore, buoyed by growth in branded marke... Read More
New Delhi, Oct. 23 -- US drugmaker Eli Lilly has struck a deal with domestic drug giant Cipla Ltd to widen the reach of its blockbuster weight loss drug tirzepatide, doubling down on India's booming m... Read More
New Delhi, Oct. 22 -- Biocon Biologics Ltd is aiming to expand its insulin portfolio in the US market, as global innovators focus on more lucrative anti-obesity GLP-1 therapies. Biocon Ltd's biosimil... Read More
New Delhi, Oct. 21 -- Indian drugmakers are expected to post steady earnings growth for the quarter ended 30 September, gaining from continued traction across global markets, although domestic sales m... Read More
New Delhi, Oct. 13 -- A piece of US legislation from 2024 that aimed to curb American companies' ties to certain Chinese biotechs has made a comeback - and Indian contract drug manufacturers are prime... Read More
New Delhi, Oct. 9 -- Dealmaking in India's pharma sector has surged over the past two years as companies seek to beef up their portfolios and reduce reliance on the US market. Yet, some of the country... Read More
New Delhi, Oct. 5 -- Two Indian drugmakers have come under regulatory scrutiny after cough syrups made by them were linked to a number of child deaths in Madhya Pradesh and Rajasthan. The central drug... Read More
New Delhi, Sept. 24 -- Glenmark Pharmaceuticals Ltd on Wednesday announced a licensing deal with Chinese drugmaker Hengrui Pharma for its under-development lung and breast cancer drug. The deal involv... Read More